Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$2.1 million.

  • Abivax's Other Operating Expenses fell 12949.78% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 24482.29%. This contributed to the annual value of $6.4 million for FY2024, which is 852.5% down from last year.
  • As of Q3 2025, Abivax's Other Operating Expenses stood at -$2.1 million, which was down 12949.78% from -$762940.8 recorded in Q2 2025.
  • Abivax's 5-year Other Operating Expenses high stood at $11.8 million for Q4 2024, and its period low was -$2.4 million during Q2 2024.